Clinical Outcomes Following Surgical Debridement of Diabetic Foot Infection with Borderline Vascularity
NCT ID: NCT05553509
Last Updated: 2024-11-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
70 participants
OBSERVATIONAL
2023-01-01
2025-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Offloading Interventions for Diabetic Foot Problems in Upper Egypt
NCT03215953
Amputation Associated Factors and Prediction Model in Diabetic Foot Patients
NCT05186519
Pattern and Type of Amputation and Mortality Rate Associated With Diabetic Foot in Jeddah, Saudi Arabia: A Retrospective Cohort Study
NCT05123157
Functional Outcome of Free Muscle Flaps Versus Free Skin Flaps for Post-traumatic Foot Plantar Surface Reconstruction
NCT03152812
Toe Amputations in Patients With Diabetes
NCT05855980
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ANGIOPLASTY GROUP
All patients undergoing PTA are going to be classified according to GLASS staging system
PER CUTANEOUS TRANSLUMINAL ANGIOPLASTY
SURGICAL DEBRIDEMNT
DEBRIDEMENT GROUP
The most commonly used technique for diabetic foot ulcers is sharp or surgical debridement using a scalpel, tissue forceps or similar instruments. It should be sufficiently extensive to remove all infected and necrotic tissue;
PER CUTANEOUS TRANSLUMINAL ANGIOPLASTY
SURGICAL DEBRIDEMNT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PER CUTANEOUS TRANSLUMINAL ANGIOPLASTY
SURGICAL DEBRIDEMNT
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
Severely infected/ gangrenous wounds requiring amputation hindering possible limb salvage.
Lesions lying within or adjacent to an aneurysm; Non diabetic cases with foot ulcers; Arteritic lesions;(Vasculitic Patients). Patients had prior major amputation, bypass surgery, and endarterectomy on any vessel of the ipsilateral (target) extremity
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kareem Ayman Hussien Shaamash
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of vascular surgery - Assiut University Hospital
Asyut, Asyut Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AST-KASH-ENDO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.